{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:14:29Z","timestamp":1773922469612,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T00:00:00Z","timestamp":1525478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00296-018-4040-2","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T04:59:31Z","timestamp":1525496371000},"page":"1777-1789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Renal involvement in antiphospholipid syndrome"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-5854","authenticated-orcid":false,"given":"Francisco Vileimar Andrade","family":"de Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-4790","authenticated-orcid":false,"given":"Diego Germano","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-0844","authenticated-orcid":false,"given":"Jozelio Freire","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-6782","authenticated-orcid":false,"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,5]]},"reference":[{"key":"4040_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"4040_CR2","first-page":"1268","volume":"20","author":"RA Asherson","year":"1993","unstructured":"Asherson RA, Kant KS (1993) Antiphospholipid antibodies and the kidney. J Rheumatol 20:1268\u20131272","journal-title":"J Rheumatol"},{"key":"4040_CR3","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508\u2013512","journal-title":"J Rheumatol"},{"key":"4040_CR4","first-page":"1181","volume":"19","author":"MC Amigo","year":"1992","unstructured":"Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA (1992) Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19:1181\u20131185","journal-title":"J Rheumatol"},{"key":"4040_CR5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","volume":"10","author":"D Nochy","year":"1999","unstructured":"Nochy D, Daugas E, Droz D et al (1999) The intra renal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507\u2013518","journal-title":"J Am Soc Nephrol"},{"key":"4040_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","volume":"13","author":"E Daugas","year":"2002","unstructured":"Daugas E, Nochy D, Huong DT et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13:42\u201352","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"4040_CR7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.20433","volume":"50","author":"MG Tektonidou","year":"2004","unstructured":"Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569\u20132579","journal-title":"Arthritis Rheum"},{"key":"4040_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1191\/0961203305lu2058oa","volume":"14","author":"DP D\u2019Cruz","year":"2005","unstructured":"D\u2019Cruz DP (2005) Renal manifestations of the antiphospholipid syndrome. Lupus 14:45\u201348","journal-title":"Lupus"},{"key":"4040_CR9","first-page":"795","volume":"68","author":"P Kincaid-Smith","year":"1998","unstructured":"Kincaid-Smith P, Fairley KF, Kloss M (1998) Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Q J Med 68:795\u2013815","journal-title":"Q J Med"},{"key":"4040_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13075-015-0614-5","volume":"17","author":"J Gerhardsson","year":"2015","unstructured":"Gerhardsson J, Sundelin B, Zickert A, Padyukov L, Svenungsson E, Gunnarsson I (2015) Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up. Arthritis Res Ther 17:109","journal-title":"Arthritis Res Ther"},{"key":"4040_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/rheumatology\/40.8.863","volume":"40","author":"KE Moss","year":"2001","unstructured":"Moss KE, Isenberg DA (2001) Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology 40:863\u2013867","journal-title":"Rheumatology"},{"key":"4040_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0961203310395051","volume":"20","author":"R Cervera","year":"2011","unstructured":"Cervera R, Tektonidou MG, Espinosa G et al (2011) Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20:165\u2013173","journal-title":"Lupus"},{"key":"4040_CR13","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2215\/CJN.00460110","volume":"5","author":"RA Sinico","year":"2010","unstructured":"Sinico RA, Cavazzana I, Nuzzo M et al (2010) Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol 5:1211\u20131217","journal-title":"Clin J Am Soc Nephrol"},{"key":"4040_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","volume":"60","author":"KS Kant","year":"1981","unstructured":"Kant KS, Pollak VE, Weiss MS, Glueck HI, Miller AN, Hess EV (1981) Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 60:71\u201386","journal-title":"Medicine (Baltimore)"},{"key":"4040_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Noel LH, Zuber J et al (2003) The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 41:1205\u20131211","journal-title":"Am J Kidney Dis"},{"key":"4040_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ki.1991.155","volume":"39","author":"G Frampton","year":"1991","unstructured":"Frampton G, Hicks J, Cameron JS (1991) Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int 39:1225\u20131231","journal-title":"Kidney Int"},{"key":"4040_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0961203310397410","volume":"20","author":"R Silvari\u00f1o","year":"2011","unstructured":"Silvari\u00f1o R, Sant F, Espinosa G, Pons-Estel G, Sol\u00e9 M, Cervera R, Arrizabalaga P (2011) Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus 20:721\u2013729","journal-title":"Lupus"},{"key":"4040_CR18","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/ar2736","volume":"11","author":"H Zheng","year":"2009","unstructured":"Zheng H, Chen Y, Ao W et al (2009) Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther 11:R93","journal-title":"Arthritis Res Ther"},{"key":"4040_CR19","first-page":"1983","volume":"35","author":"MG Tektonidou","year":"2008","unstructured":"Tektonidou MG, Sotsiou F, Moutsopoulos HM (2008) Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol 35:1983\u20131988","journal-title":"J Rheumatol"},{"key":"4040_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","volume":"93","author":"MH Griffiths","year":"2000","unstructured":"Griffiths MH, Papadaki L, Neild GH (2000) The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. QJM 93:457\u2013467","journal-title":"QJM"},{"key":"4040_CR21","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3899\/jrheum.151395","volume":"43","author":"R Gao","year":"2016","unstructured":"Gao R, Yu W, Wen Y,li H (2016) Beta2-glycoprotein I expression in lupus nephritis patients with antiphospholipid-associated nephropathy. J Rheumatol 43:2026\u20132032","journal-title":"J Rheumatol"},{"key":"4040_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/01.CIR.98.11.1092","volume":"98","author":"J Frostegard","year":"1998","unstructured":"Frostegard J, Wu R, Gillis-Haegerstrand C, Lemne C, de Faire U (1998) Antibodies to endothelial cells in borderline hypertension. Circulation 98:1092\u20131098","journal-title":"Circulation"},{"key":"4040_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1191\/0961203304lu1082oa","volume":"13","author":"C Rollino","year":"2004","unstructured":"Rollino C, Boero R, Elia F et al (2004) Antiphospholipid antibodies and hypertension. Lupus 13:769\u2013772","journal-title":"Lupus"},{"key":"4040_CR24","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/ndt\/4.10.854","volume":"4","author":"D Kleinknecht","year":"1989","unstructured":"Kleinknecht D, Bobrie G, Meyer O, No\u00ebl LH, Callard P, Ramdane M (1989) Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 4:854\u2013858","journal-title":"Nephrol Dial Transplant"},{"key":"4040_CR25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2215\/CJN.00240110","volume":"5","author":"A Smyth","year":"2010","unstructured":"Smyth A, Oliveira GH, Lahr BD et al (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5:2060\u20132068","journal-title":"Clin J Am Soc Nephrol"},{"key":"4040_CR26","first-page":"479","volume":"11","author":"P Cacoub","year":"1993","unstructured":"Cacoub P, Wechsler B, Piette JC et al (1993) Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin Exp Rheumatol 11:479\u2013485","journal-title":"Clin Exp Rheumatol"},{"key":"4040_CR27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/ard.56.9.562","volume":"56","author":"NS Lai","year":"1997","unstructured":"Lai NS, Lan JL (1997) Renal vein thrombosis in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis 56:562\u2013564","journal-title":"Ann Rheum Dis"},{"key":"4040_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","volume":"26","author":"R Prakash","year":"1995","unstructured":"Prakash R, Miller CC 3rd, Suki WN (1995) Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 26:347\u2013352","journal-title":"Am J Kidney Dis"},{"key":"4040_CR29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","volume":"7","author":"SL Chew","year":"1992","unstructured":"Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J (1992) Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 7:1194\u20131198","journal-title":"Nephrol Dial Transplant"},{"key":"4040_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","volume":"91","author":"S Bhandari","year":"1998","unstructured":"Bhandari S, Harnden P, Brownjohn AM, Turney JH (1998) Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 91:401\u2013409","journal-title":"QJM"},{"key":"4040_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/rheumatology\/30.6.422","volume":"30","author":"B Leaker","year":"1991","unstructured":"Leaker B, McGregor A, Griffiths M, Snaith M, Neild GH, Isenberg D (1991) Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br J Rheumatol 30:422\u2013425","journal-title":"Br J Rheumatol"},{"key":"4040_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","volume":"43","author":"G Moroni","year":"2004","unstructured":"Moroni G, Ventura D, Riva P et al (2004) Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43:28\u201336","journal-title":"Am J Kidney Dis"},{"key":"4040_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.1998.tb00995.x","volume":"12","author":"S Vaidya","year":"1998","unstructured":"Vaidya S, Wang CC, Gugliuzza C, Fish JC (1998) Relative risk of pos-transplant renal thrombosis in patients with antiphospholipid antibodies. Clin Transplant 12:439\u2013444","journal-title":"Clin Transplant"},{"key":"4040_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1191\/096120398678920811","volume":"7","author":"JH Stone","year":"1998","unstructured":"Stone JH (1998) End-stage renal disease in lupus: disease activity, dialysis, and the outcome of transplantation. Lupus 7:654\u2013659","journal-title":"Lupus"},{"key":"4040_CR35","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1046\/j.1600-6143.2004.00602.x","volume":"4","author":"JP Forman","year":"2004","unstructured":"Forman JP, Lin J, Pascual M et al (2004) Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant 4:1786\u20131791","journal-title":"Am J Transplant"},{"key":"4040_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0272-6386(12)80986-3","volume":"23","author":"J Radhakrishnan","year":"1994","unstructured":"Radhakrishnan J, Williams GS, Appel GB, Cohen DJ (1994) Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kidney Dis 23:286\u2013289","journal-title":"Am J Kidney Dis"},{"key":"4040_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00007890-199907270-00014","volume":"68","author":"D WagenKnecht","year":"1999","unstructured":"WagenKnecht D, Becker DG, Lefor WM, McIntyre JA (1999) Antiphosphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 68:241\u2013246","journal-title":"Transplantation"},{"key":"4040_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/TP.0000000000001199","volume":"101","author":"JM Morales","year":"2017","unstructured":"Morales JM, Serrano M, Martinez-Flores JA et al (2017) The presence of pretransplant antiphospholipid antibodies IgA anti-beta-2-glycoprotein I as a predictor of graft thrombosis after renal transplantation. Transplantation 101:597\u2013607","journal-title":"Transplantation"},{"key":"4040_CR39","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1161\/CIRCULATIONAHA.116.025992","volume":"135","author":"M Serrano","year":"2017","unstructured":"Serrano M, Mart\u00ednez-Flores JA, P\u00e9rez D et al (2017) \u03b22-Glycoprotein I\/IgA immune complexes: a marker to predict thrombosis after renal transplantation in patients with antiphospholipid antibodies. Circulation 135:1922\u20131934","journal-title":"Circulation"},{"key":"4040_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00007890-199901150-00015","volume":"67","author":"D Ducloux","year":"1999","unstructured":"Ducloux D, Pellet E, Fournier V et al (1999) Prevalence and clinical significance of antibodies in renal transplant recipients. Transplantation 67:90\u201393","journal-title":"Transplantation"},{"key":"4040_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar4549","volume":"16","author":"PL Meroni","year":"2014","unstructured":"Meroni PL, Chighizola CB, Rovelli F, Gerosa M (2014) Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther 16:209","journal-title":"Arthritis Res Ther"},{"key":"4040_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","volume":"12","author":"KA Krone","year":"2010","unstructured":"Krone KA, Allen KL, McCrae KR (2010) Impaired fibrinolysis in the antiphospholipid syndrome. Curr Rheumatol Rep 12:53\u201357","journal-title":"Curr Rheumatol Rep"},{"key":"4040_CR43","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/jth.12722","volume":"12","author":"DR Arachchillage","year":"2014","unstructured":"Arachchillage DR, Efthymiou M, Mackie IJ et al (2014) Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome. J Thromb Haemost 12:1801\u20131809","journal-title":"J Thromb Haemost"},{"key":"4040_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.thromres.2013.08.015","volume":"132","author":"KJ Brandt","year":"2013","unstructured":"Brandt KJ, Kruithof EK, de Moerloose P (2013) Receptors involved in cell activation by antiphospholipid antibodies. Thromb Res 132:408\u2013413","journal-title":"Thromb Res"},{"key":"4040_CR45","first-page":"56","volume":"52","author":"H S\u00e1","year":"1999","unstructured":"S\u00e1 H, Freitas L, Mota A et al (1999) Primary antiphospholipid syndrome presented by total infarction of right kidney with nephrotic syndrome. Clin Nephrol 52:56\u201360","journal-title":"Clin Nephrol"},{"key":"4040_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0049-3848(93)90176-O","volume":"71","author":"LW Chamley","year":"1993","unstructured":"Chamley LW, McKay EJ, Pattison NS (1993) Inhibition of heparin\/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb Res 71:103\u2013111","journal-title":"Thromb Res"},{"key":"4040_CR47","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.4049\/jimmunol.167.12.7192","volume":"167","author":"KK Hwang","year":"2001","unstructured":"Hwang KK, Grossman JM, Visvanathan S et al (2001) Identification of antithrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol 167:7192\u20137198","journal-title":"J Immunol"},{"key":"4040_CR48","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.4049\/jimmunol.182.3.1674","volume":"182","author":"YH Yang","year":"2009","unstructured":"Yang YH, Chien D, Wu M et al (2009) Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin. J Immunol 182:1674\u20131680","journal-title":"J Immunol"},{"key":"4040_CR49","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2006-07-030148","volume":"109","author":"B Laat de","year":"2007","unstructured":"de Laat B, Wu XX, van Lummel M et al (2007) Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109:1490\u20131494","journal-title":"Blood"},{"key":"4040_CR50","doi-asserted-by":"publisher","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","volume":"95","author":"GM Iverson","year":"1998","unstructured":"Iverson GM, Victoria EJ, Marquis DM (1998) Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci USA 95:15542\u201315546","journal-title":"Proc Natl Acad Sci USA"},{"key":"4040_CR51","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.4049\/jimmunol.169.12.7097","volume":"169","author":"GM Iverson","year":"2002","unstructured":"Iverson GM, Reddel S, Victoria EJ et al (2002) Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol 169:7097\u20137103","journal-title":"J Immunol"},{"key":"4040_CR52","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1182\/blood-2010-08-300715","volume":"117","author":"A Arad","year":"2011","unstructured":"Arad A, Proulle V, Furie RA et al (2011) Beta(2)-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood 117:3453\u20133459","journal-title":"Blood"},{"key":"4040_CR53","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1182\/blood-2010-11-316158","volume":"117","author":"N Satta","year":"2011","unstructured":"Satta N, Kruithof EK, Fickentscher C et al (2011) Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood 117:5523\u20135531","journal-title":"Blood"},{"key":"4040_CR54","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/art.22802","volume":"56","author":"M Sorice","year":"2007","unstructured":"Sorice M, Longo A, Capozzi A et al (2007) Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 56:2687\u20132697","journal-title":"Arthritis Rheum"},{"key":"4040_CR55","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/art.21968","volume":"54","author":"T Shi","year":"2006","unstructured":"Shi T, Giannakopoulos B, Yan X et al (2006) Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum 54:2558\u20132567","journal-title":"Arthritis Rheum"},{"key":"4040_CR56","first-page":"51","volume":"25","author":"DL Robbins","year":"1998","unstructured":"Robbins DL, Leung S, Miller-Blair DJ, Ziboh V (1998) Effect of anticardiolipin\/ beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome. J Rheumatol 25:51\u201356","journal-title":"J Rheumatol"},{"key":"4040_CR57","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","volume":"114","author":"SV Seshan","year":"2009","unstructured":"Seshan SV, Franzke CW, Redecha P et al (2009) Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood 114:1675\u20131683","journal-title":"Blood"},{"key":"4040_CR58","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/art.34440","volume":"64","author":"I Shapira","year":"2012","unstructured":"Shapira I, Andrade D, Allen SL, Salmon JE (2012) Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis Rheum 64:2719\u20132723","journal-title":"Arthritis Rheum"},{"key":"4040_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1056\/NEJMoa1312890","volume":"371","author":"G Canaud","year":"2014","unstructured":"Canaud G, Bienaime F, Tabarin F et al (2014) Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 371:303\u2013312","journal-title":"N Engl J Med"},{"key":"4040_CR60","first-page":"1413","volume":"18","author":"RA Asherson","year":"1991","unstructured":"Asherson RA, Noble GE, Hughes GR (1991) Hypertension, renal artery stenosis and the \u201cprimary\u201d antiphospholipid syndrome. J Rheumatol 18:1413\u20131415","journal-title":"J Rheumatol"},{"issue":"11","key":"4040_CR61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1191\/0961203303lu493ed","volume":"12","author":"SR Sangle","year":"2003","unstructured":"Sangle SR, D\u2019Cruz DP (2003) Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus 12(11):803\u2013804","journal-title":"Lupus"},{"key":"4040_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0002-9343(90)90262-C","volume":"88","author":"JW Olin","year":"1990","unstructured":"Olin JW, Melia M, Young JR, Graor RA, Risius B (1990) Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88:46\u201351","journal-title":"Am J Med"},{"key":"4040_CR63","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/rheumatology\/keh490","volume":"44","author":"SR Sangle","year":"2005","unstructured":"Sangle SR, D\u2019Cruz DP, Abbs IC, Khamashta MA, Hughes GR (2005) Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology 44:372\u2013377","journal-title":"Rheumatology"},{"key":"4040_CR64","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5414\/CNP63471","volume":"63","author":"A Saracino","year":"2005","unstructured":"Saracino A, Ramunni A, Pannarale G, Coratelli P (2005) Kidney disease associated with primary antiphospholipid syndrome: clinica signs and histopathological features in a case experience of five cases. Clin Nephrol 63:471","journal-title":"Clin Nephrol"},{"key":"4040_CR65","first-page":"166","volume":"72","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Aledort LM (2005) Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. Mt Sinai J Med 72:166\u2013175","journal-title":"Mt Sinai J Med"},{"key":"4040_CR66","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/096120339900800613","volume":"8","author":"KC Cerveny","year":"1999","unstructured":"Cerveny KC, Sawitzke AD (1999) Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura? Lupus 8:477\u2013481","journal-title":"Lupus"},{"key":"4040_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0272-6386(89)80001-0","volume":"13","author":"HG Rennke","year":"1989","unstructured":"Rennke HG, Klein PS (1989) Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13:443","journal-title":"Am J Kidney Dis"},{"key":"4040_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/096120339400300106","volume":"3","author":"JM Miranda","year":"1994","unstructured":"Miranda JM, Garcia-Torres R, Jara LJ, Medina F, Cervera H, Fraga A (1994) Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 3:25\u201329","journal-title":"Lupus"},{"key":"4040_CR69","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/0046-8177(95)90218-X","volume":"26","author":"MD Hughson","year":"1995","unstructured":"Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 26:716\u2013724","journal-title":"Hum Pathol"},{"key":"4040_CR70","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.V15777","volume":"1","author":"V D\u2019Agati","year":"1990","unstructured":"D\u2019Agati V, Kunis C, Williams G, Appel GB (1990) Anti-cardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1:777\u2013784","journal-title":"J Am Soc Nephrol"},{"key":"4040_CR71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.reuma.2008.12.011","volume":"5","author":"JM Miranda","year":"2009","unstructured":"Miranda JM, Jara LJ, Calleja C, Saavedra MA, Bustamante RM, Angeles U (2009) Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE). Reumatol Clin 5:209\u2013213","journal-title":"Reumatol Clin"},{"key":"4040_CR72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","volume":"10","author":"D Erkan","year":"2010","unstructured":"Erkan D, Espinosa G, Cervera R (2010) Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 10:74\u201379","journal-title":"Autoimmun Rev"},{"key":"4040_CR73","first-page":"2817","volume":"27","author":"D Erkan","year":"2000","unstructured":"Erkan D, Yazici Y, Sobel R, Lockshin MD (2000) Primary antiphospholipid syndrome: functional outcome after 10\u00a0years. J Rheumatol 27:2817\u20132821","journal-title":"J Rheumatol"},{"key":"4040_CR74","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","volume":"6","author":"F Garcia-Martin","year":"1991","unstructured":"Garcia-Martin F, De Arriba G, Carrascosa T et al (1991) Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 6:543\u2013547","journal-title":"Nephrol Dial Transplant"},{"key":"4040_CR75","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"American College of Obstetricians and Gynecologists, Task force on hypertension in pregnancy","year":"2013","unstructured":"American College of Obstetricians and Gynecologists, Task force on hypertension in pregnancy (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists \u2018Task Force on hypertension in pregnancy\u2019 Obstet Gynecol 122:1122","journal-title":"Obstet Gynecol"},{"key":"4040_CR76","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","volume":"103","author":"BM Sibai","year":"2004","unstructured":"Sibai BM (2004) Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103:981","journal-title":"Obstet Gynecol"},{"key":"4040_CR77","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1074\/jbc.M110176200","volume":"277","author":"J Guerin","year":"2002","unstructured":"Guerin J, Sheng Y, Reddel S, Iverson GM, Chapman MG, Krilis SA (2002) Heparin inhibits the binding of \u03b22-glycoprotein I to phospholipids and promotes the plasmin mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem 277:2644\u20132649","journal-title":"J Biol Chem"},{"key":"4040_CR78","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","volume":"295","author":"W Lim","year":"2006","unstructured":"Lim W, Crowther MA, Eikelboom JW (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295:1050\u20131057","journal-title":"JAMA"},{"key":"4040_CR79","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJMoa035241","volume":"349","author":"MA Crowther","year":"2003","unstructured":"Crowther MA, Ginsberg JS, Julian J et al (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349:1133\u20131138","journal-title":"N Engl J Med"},{"key":"4040_CR80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00296-010-1559-2","volume":"32","author":"H Peleg","year":"2012","unstructured":"Peleg H, Bursztyn M, Hiller N, Hershcovici T (2012) Renal artery stenosis with significant proteinuria may be reversed after nephrectomy or revascularization in patients with the antiphospholipid antibody syndrome: a case series and review of the literature. Rheumatol Int 32:85\u201390","journal-title":"Rheumatol Int"},{"key":"4040_CR81","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","volume":"13","author":"R Cervera","year":"2014","unstructured":"Cervera R, Rodr\u00edguez-Pint\u00f3 I, Colafrancesco S et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmun Rev 13:699\u2013707","journal-title":"Autoimmun Rev"},{"key":"4040_CR82","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1111\/j.1600-6143.2011.03696.x","volume":"11","author":"K Hadaya","year":"2011","unstructured":"Hadaya K, Ferrari-Lacraz S, Fumeaux D et al (2011) Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant 11:2523\u20132527","journal-title":"Am J Transplant"},{"key":"4040_CR83","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/ajt.12319","volume":"13","author":"G Canaud","year":"2013","unstructured":"Canaud G, Kamar N, Anglicheau D et al (2013) Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes. Am J Transplant 13:2179\u20132185","journal-title":"Am J Transplant"},{"key":"4040_CR84","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJMc0910965","volume":"362","author":"BE Lonze","year":"2010","unstructured":"Lonze BE, Singer AL, Montgomery RA (2010) Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med 362:1744\u20131745","journal-title":"N Engl J Med"},{"key":"4040_CR85","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","volume":"46","author":"A Klos","year":"2009","unstructured":"Klos A, Tenner AJ, Johswich K-O et al (2009) The role of the anaphylatoxins in health and disease. Mol Immunol 46:2753\u20132766","journal-title":"Mol Immunol"},{"key":"4040_CR86","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","volume":"28","author":"DRW Jayne","year":"2017","unstructured":"Jayne DRW, Bruchfeld NA, Harper L et al (2017) Randomized trial of c5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 28:2756\u20132767","journal-title":"J Am Soc Nephrol"},{"key":"4040_CR87","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ajh.23797","volume":"89","author":"K Win","year":"2014","unstructured":"Win K, Rodgers GM (2014) New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome. Am J Hematol 89:1017","journal-title":"Am J Hematol"},{"key":"4040_CR88","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/art.37759","volume":"65","author":"D Erkan","year":"2013","unstructured":"Erkan D, Vega J, Ramon G, Kozora E, Lockshin MD (2013) A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum 65:464\u2013471","journal-title":"Arthritis Rheum"},{"key":"4040_CR89","first-page":"215","volume":"14","author":"G Tsagalis","year":"2010","unstructured":"Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A (2010) Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab. Hippokratia 14:215\u2013216","journal-title":"Hippokratia"},{"key":"4040_CR90","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/01.TP.0000119157.81765.46","volume":"77","author":"S Vaidya","year":"2004","unstructured":"Vaidya S, Gugliuzza K, Daller J (2004) Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 77:1046\u20131049","journal-title":"Transplantation"},{"key":"4040_CR91","doi-asserted-by":"publisher","first-page":"844S","DOI":"10.1378\/chest.08-0761","volume":"133","author":"SM Bates","year":"2008","unstructured":"Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy: american college of chest physicians Evidence-based clinical practice guidelines (8th\u00a0edn). Chest 133:844S\u2013886S","journal-title":"Chest"},{"key":"4040_CR92","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0272-6386(12)70258-5","volume":"20","author":"E Farrugia","year":"1992","unstructured":"Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE (1992) Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 20:463\u2013471","journal-title":"Am J Kidney Dis"},{"key":"4040_CR93","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0272-6386(12)80885-7","volume":"18","author":"G Banfi","year":"1991","unstructured":"Banfi G, Bertani T, Boeri V et al (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18:240\u2013248","journal-title":"Am J Kidney Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4040-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:41:04Z","timestamp":1751607664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4040-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,5]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4040-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,5]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interests regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}